RecruitingNCT05103254

Bempedoic Acid Pregnancy Surveillance Program

A Post-marketing, Long-term, Observational, Descriptive Study to Assess the Risk of Pregnancy and Maternal Complications and Adverse Effects on the Developing Fetus, Neonate, and Infant Among Women Exposed to Bempedoic Acid or Bempedoic Acid/Ezetimibe Fixed Combination Drug Product (FCDP) During Pregnancy

Sponsor

Esperion Therapeutics, Inc.

Enrollment

20 participants

Start Date

Sep 1, 2021

Study Type

OBSERVATIONAL

Conditions

Pregnancy Hyperlipidemias

Summary

Bempedoic acid pregnancy surveillance program

Eligibility

Sex: FEMALEMin Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Bempedoic Acid and a drug called Bempedoic Acid / Ezetimibe for people with hyperlipidemias and pregnancy. The study is currently recruiting participants at 1 location. People eligible for this study include women aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.